HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1038987Generated: November 1, 2026
HCID 58379677, compound → HCID 58379688, compound
https://huagongshe.com/reaction/1038987
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | HCID 58379677 | HCID 58379677 | — |
| Reactant | HCID 178418361 | HCID 178418361 | — |
| Catalyst | Palladium | HCID 23938 | — |
| Solvent | Methanol | HCID 887 | — |
| Product | HCID 58379688 | HCID 58379688 | — |
Reaction Steps
To a nitrogen purged solution of N-Benzyl-2,2-dimethyl-N-[3-(2′-oxo-1,1′,2′,3-tetrahydrospiro[indene-2,3′-pyrrolo[2,3-b]pyridin]-5-yl)prop-2-yn-1-yl]propanamide (42 mg, 0.91 mmol, Example 1) in MeOH (4 mL) was added 10% Pd/C (19 mg). The nitrogen atmosphere was exchanged for a hydrogen atmosphere using a hydrogen balloon, and then a fresh hydrogen balloon was attached. After 1 hour a mixture of alkene/alkane was observed. Allow reaction to stir for 20 hours under an atmosphere of hydrogen. The hydrogen atmosphere was then exchanged for a nitrogen atmosphere, and the mixture was filtered through celite, and washed with additional MeOH. The combined organics were concentrated in vacuo to yield a residue. The residue was then applied to a silica gel column for purification, eluting with a gradient of 1-7% MeOH in DCM to give the title compound. MS: m/z=468 (M+1). Human CGRP receptor binding Ki=45 nM. HRMS: m/z=468.2632; calculated m/z=468.2642 for C30H34N3O2.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08552023B2 |
|---|
| Source dataset | uspto-grants-2013_10 |
|---|
| ORD ID | ord-310e02f5ab014f659bc233068298152c |
|---|
| Source note | uspto-grants-2013_10 |
|---|